Device Trial Radar · NCT03664609
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5,000
Planned (sponsor's estimate)
Start
Mar 12, 2019
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Sep 10, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Conditions
- Parkinson Disease
- Essential Tremor
- Dystonia
Interventions
Deep Brain StimulationDevice
Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baselineTime frame: 5 yrs. post implant
Locations
20 sites in 6 countries. Site status is shown where the registry gives one.
St. Joseph's Hospital & Medical Center
Phoenix, Arizona · Recruiting
Riverside University Health System
Moreno Valley, California · Recruiting
University of California, San Francisco
San Francisco, California · Recruiting
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.